The Presence of Donor-Specific Antibodies in Renal Transplantation
dc.authorid | Gürkan, Hakan/0000-0002-8967-6124 | |
dc.authorid | SARI, Gulce/0000-0002-8585-5889 | |
dc.authorwosid | Gürkan, Hakan/AAF-2866-2020 | |
dc.authorwosid | Sagiroglu, Gonul/ABH-1345-2021 | |
dc.authorwosid | sagiroglu, gönül/AAB-4472-2021 | |
dc.contributor.author | Tozkir, H. | |
dc.contributor.author | Sagiroglu, T. | |
dc.contributor.author | Kilicarslan-Ayna, T. | |
dc.contributor.author | Tan, S. | |
dc.contributor.author | Copuroglu, E. | |
dc.contributor.author | Sagiroglu, G. | |
dc.contributor.author | Sari, G. | |
dc.date.accessioned | 2024-06-12T11:17:38Z | |
dc.date.available | 2024-06-12T11:17:38Z | |
dc.date.issued | 2012 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description | 8th Congress of the Turkish-Transplantation-Centers-Coordination-Association (TTCCA) -- OCT 12-16, 2011 -- Antalya, TURKEY | en_US |
dc.description.abstract | Determining the presence of anti-HLA antibodies before transplantation is an important factor to prevent loss of function among renal transplantations. In addition, recent studies have shown that not only the pretransplantation existence of anti-HLA antibody but also posttransplantation donor-specific antibodies (DSA) and non-donor-specific antibodies are significantly associated with allograft rejection or loss of graft function. This study presented DSA among patients after renal transplantation together with graft function and survival. | en_US |
dc.description.sponsorship | Turkish Transplantat Ctr Coordinat Assoc (TTCCA) | en_US |
dc.identifier.doi | 10.1016/j.transproceed.2012.05.052 | |
dc.identifier.endpage | 1669 | en_US |
dc.identifier.issn | 0041-1345 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 22841240 | en_US |
dc.identifier.scopus | 2-s2.0-84864413906 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 1667 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.transproceed.2012.05.052 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/24785 | |
dc.identifier.volume | 44 | en_US |
dc.identifier.wos | WOS:000307433400055 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Inc | en_US |
dc.relation.ispartof | Transplantation Proceedings | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Assay | en_US |
dc.title | The Presence of Donor-Specific Antibodies in Renal Transplantation | en_US |
dc.type | Conference Object | en_US |